JPMorgan Chase Exec Sued for Drugging, Sex‑Slave Abuse Claims

A lawsuit filed in New York County Supreme Court accuses a senior JPMorgan Chase executive of subjecting a male colleague to repeated sexual assault, drugging, and coercion in exchange for career favours.

The complaint, lodged by a plaintiff identified only as “John Doe,” alleges that Lorna Hajdini, 37, who joined the bank’s New York office in April 2024, used her senior position to force the junior banker into “non‑consensual and humiliating sex acts.” According to the filing, Hajdini threatened the employee with damage to his career, stating, “If you don’t fk me soon, I’m going to ruin you… I fking own you.” The suit further claims she administered a “date‑rape drug” and other substances intended to affect sexual performance, while manipulating bonuses, promotions and future employment prospects to secure compliance.

JPMorgan Chase has denied the allegations, stating that an internal investigation found no evidence to support the plaintiff’s claims. The bank’s response, cited by The Sun, emphasizes that the findings were based on a comprehensive review of relevant records and personnel interviews.

Court documents filed on Monday list both Hajdini and JPMorgan Chase as defendants, but the publicly available filing does not disclose the specific details of the allegations beyond the plaintiff’s identifier and the nature of the complaint. The case is pending further proceedings in the New York state court system.

The lawsuit emerges amid a series of legal and reputational challenges facing JPMorgan Chase. In recent years the bank has settled multiple suits related to its historic relationship with convicted sex offender Jeffrey Epstein. Plaintiffs alleged that the bank ignored warning signs, such as large cash withdrawals, and provided financial services that facilitated Epstein’s sex‑trafficking operations. JPMorgan Chase paid $290 million and $75 million in 2023 to resolve those claims, without admitting wrongdoing.

In addition, former President Donald Trump filed a $5 billion suit in January 2024 accusing JPMorgan Chase of “de‑banking” his businesses for political reasons. The bank has rejected that claim and is seeking dismissal.

The current case adds to heightened scrutiny of JPMorgan Chase’s workplace culture and internal controls. If the plaintiff’s allegations are substantiated, they could prompt further regulatory reviews and potentially influence the bank’s policies on harassment, drug use, and power dynamics within its ranks. The outcome of the litigation will likely be watched closely by financial institutions and legal observers alike.